A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial

Project: Research

Project Details

Project Description

Effective start/end date28/09/2127/09/26


  • phase 3 clinical trial
  • treatment efficacy
  • treatment safety
  • advanced tumours